Your browser doesn't support javascript.
loading
Covalent targeting the LAS1-NOL9 axis for selective treatment in NPM1 mutant acute myeloid leukemia.
Han, Yefan; Hu, Anni; Qu, Yi; Xu, Qianqian; Wang, Hang; Feng, Yin; Hu, Yili; He, Li; Wu, Hao; Wang, Xinzhi.
Afiliación
  • Han Y; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China; Jiangsu Key Laboratory of Research and Development in Marine Bio-resource Pharmaceutics, Nanjing 210046, China.
  • Hu A; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China; Jiangsu Key Laboratory of Research and Development in Marine Bio-resource Pharmaceutics, Nanjing 210046, China.
  • Qu Y; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China; Jiangsu Key Laboratory of Research and Development in Marine Bio-resource Pharmaceutics, Nanjing 210046, China.
  • Xu Q; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China; Jiangsu Key Laboratory of Research and Development in Marine Bio-resource Pharmaceutics, Nanjing 210046, China.
  • Wang H; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China; Jiangsu Key Laboratory of Research and Development in Marine Bio-resource Pharmaceutics, Nanjing 210046, China.
  • Feng Y; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China; Jiangsu Key Laboratory of Research and Development in Marine Bio-resource Pharmaceutics, Nanjing 210046, China.
  • Hu Y; Experiment Center for Science and Technology, Nanjing University of Chinese Medicine, Nanjing 210046, China.
  • He L; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • Wu H; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China.
  • Wang X; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China; Jiangsu Key Laboratory of Research and Development in Marine Bio-resource Pharmaceutics, Nanjing 210046, China. Electronic address: xinzhiwang@njucm.edu.cn.
Pharmacol Res ; 189: 106700, 2023 03.
Article en En | MEDLINE | ID: mdl-36796466

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda Límite: Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda Límite: Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China